How to Find Tiny Stocks Packing Quadruple-Digit Profit Potential

Micro-cap and penny biotech stocks (those with a market cap at less than $300 million) have a reputation for being extremely speculative,...

This "Quick Doubler" Biotech Will Likely Disappoint

Stroke kills an American every four minutes - more than 525,000 individuals each year - and nearly 300,000 more fall victim to its debilitating...

How to Protect Your Biotech Profits from This Legal Limbo

Gilead Sciences Inc.'s Sovaldi was a real breakthrough in the fight against the chronic liver disease hepatitis C (HCV). The condition may show no...

How to Make a (Consistent) Killing in Biotech Investing in 2016

Biotech is in the midst of its longest bull run in history, and there's every reason to expect it will remain an attractive outperformer this...

What Hillary's Pharma Plan Means for Biotech Investors

Martin Shkreli, CEO of Turing Pharmaceuticals, made news this week when he announced he would raise the price of a medication his company had...

Two Tactics for Bigger Biotech Investing Profits

Over the past six months, we've seen the Nasdaq Biotechnology Index, an indicator for the entire sector, take some wild swings ...

This Bioscience Company Has "Nearly Limitless" Income Potential

Medical device companies can be profit-making machines - one manufacturer of magnetic resonance imaging (MRI) machines and other high-tech...

"21st Century Cures" Could Revolutionize Biotech

No one is thrilled with the way new drugs and medical devices come to market in the U.S. - not the biotech and pharmaceutical...

How to Find the Best Biotech Shares - Every Time

When you're evaluating most new stocks, it makes good sense to look at technical indicators - such as price-to-earnings ratio (P/E), profit...

The Keryx (Nasdaq: KERX) Media Blunder Will Add to Our 700% Gain

On August 29, 2012, shares of Keryx Biopharmaceuticals - a company focused on pharmaceutical products for...

The Clear Map to This "Hidden" Investment Treasure

Ask any bioscience researcher about leading trends in medical science, and at some point, you're likely to hear a lot of...

A Clear Way to Profit from a Graying Population

The Baby Boom generation, which includes everyone born from 1946 through 1964, is now entering retirement age (65) at a rate...

The BioScience Profit Outlook for the Rest of 2014

With just six months left on my 2014 bioscience "profit calendar," things are really starting to look promising for the second...

How to Tap Big Profits in That "Other" Bioscience Niche

At first glance, it may seem like bioscience investing is so complicated and risky that it's hardly worth your time and money to invest, at least if...

Why Trailing Stops Are One of the Most Important Investment Tools Ever

Today I want to offer a deeper explanation of one of the very best investment tools: trailing stops.
Every single one of...

Pages 1 of 2 1 2